Q3 2018

Filed Nov 19, 2018 · 10-Q · 50 days after period end · 0001398432-18-000131

Q3 2018 · 10-Q

Revenue

$43.97K

+15.6% vs Q3 2017

Net Income

-$967.92K

N/M vs Q3 2017

EPS Diluted

$0.00

— vs Q3 2017

Gross Profit$6,557−80.5%

Operating Income

Same quarter

Metric	Q3 2018	Q3 2017	Q3 2016	Q3 2015
Revenue	$43.97K	$38.05K	$70.49K	$52.87K
Net Income	-$967.92K	-$981.45K	-$644.02K	-$3.94M
EPS Diluted	$0.00	$0.00	$0.00	$0.06

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR